MiR-145 functions as a tumor suppressor by directly targeting histone deacetylase 2 in liver cancer

Ji Heon Noh, Young Gyoon Chang, Min Gyu Kim, Kwang Hwa Jung, Jeong Kyu Kim, Hyun Jin Bae, Jung Woo Eun, Qingyu Shen, Seung Jin Kim, So Hee Kwon, Won Sang Park, Jung Young Lee, Suk Woo Nam

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

Aberrant regulation of histone deacetylase 2 (HDAC2) plays a pivotal role in the development of hepatocellular carcinoma (HCC), but, the underlying mechanism leading to HDAC2 overexpression is not well understood. We performed microRNA (miRNA) profiling analysis in a subset of HCCs, and identified four down-regulated miRNAs that may target HDAC2 in HCC. Ectopic expression of miRNA mimics evidenced that miR-145 suppresses HDAC2 expression in HCC cells. This treatment repressed cancer cell growth and recapitulated HDAC2 knockdown effects on HCC cells. In conclusion, we suggest that loss or suppression of miR-145 may cause aberrant overexpression of HDAC2 and promote HCC tumorigenesis.

Original languageEnglish
Pages (from-to)455-462
Number of pages8
JournalCancer Letters
Volume335
Issue number2
DOIs
Publication statusPublished - 2013 Jul 28

Fingerprint

Histone Deacetylase 2
Liver Neoplasms
Hepatocellular Carcinoma
MicroRNAs
Neoplasms
Carcinogenesis
Growth

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Noh, J. H., Chang, Y. G., Kim, M. G., Jung, K. H., Kim, J. K., Bae, H. J., ... Nam, S. W. (2013). MiR-145 functions as a tumor suppressor by directly targeting histone deacetylase 2 in liver cancer. Cancer Letters, 335(2), 455-462. https://doi.org/10.1016/j.canlet.2013.03.003
Noh, Ji Heon ; Chang, Young Gyoon ; Kim, Min Gyu ; Jung, Kwang Hwa ; Kim, Jeong Kyu ; Bae, Hyun Jin ; Eun, Jung Woo ; Shen, Qingyu ; Kim, Seung Jin ; Kwon, So Hee ; Park, Won Sang ; Lee, Jung Young ; Nam, Suk Woo. / MiR-145 functions as a tumor suppressor by directly targeting histone deacetylase 2 in liver cancer. In: Cancer Letters. 2013 ; Vol. 335, No. 2. pp. 455-462.
@article{dcb0c90aaee2452dbe861129f0f53882,
title = "MiR-145 functions as a tumor suppressor by directly targeting histone deacetylase 2 in liver cancer",
abstract = "Aberrant regulation of histone deacetylase 2 (HDAC2) plays a pivotal role in the development of hepatocellular carcinoma (HCC), but, the underlying mechanism leading to HDAC2 overexpression is not well understood. We performed microRNA (miRNA) profiling analysis in a subset of HCCs, and identified four down-regulated miRNAs that may target HDAC2 in HCC. Ectopic expression of miRNA mimics evidenced that miR-145 suppresses HDAC2 expression in HCC cells. This treatment repressed cancer cell growth and recapitulated HDAC2 knockdown effects on HCC cells. In conclusion, we suggest that loss or suppression of miR-145 may cause aberrant overexpression of HDAC2 and promote HCC tumorigenesis.",
author = "Noh, {Ji Heon} and Chang, {Young Gyoon} and Kim, {Min Gyu} and Jung, {Kwang Hwa} and Kim, {Jeong Kyu} and Bae, {Hyun Jin} and Eun, {Jung Woo} and Qingyu Shen and Kim, {Seung Jin} and Kwon, {So Hee} and Park, {Won Sang} and Lee, {Jung Young} and Nam, {Suk Woo}",
year = "2013",
month = "7",
day = "28",
doi = "10.1016/j.canlet.2013.03.003",
language = "English",
volume = "335",
pages = "455--462",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

Noh, JH, Chang, YG, Kim, MG, Jung, KH, Kim, JK, Bae, HJ, Eun, JW, Shen, Q, Kim, SJ, Kwon, SH, Park, WS, Lee, JY & Nam, SW 2013, 'MiR-145 functions as a tumor suppressor by directly targeting histone deacetylase 2 in liver cancer', Cancer Letters, vol. 335, no. 2, pp. 455-462. https://doi.org/10.1016/j.canlet.2013.03.003

MiR-145 functions as a tumor suppressor by directly targeting histone deacetylase 2 in liver cancer. / Noh, Ji Heon; Chang, Young Gyoon; Kim, Min Gyu; Jung, Kwang Hwa; Kim, Jeong Kyu; Bae, Hyun Jin; Eun, Jung Woo; Shen, Qingyu; Kim, Seung Jin; Kwon, So Hee; Park, Won Sang; Lee, Jung Young; Nam, Suk Woo.

In: Cancer Letters, Vol. 335, No. 2, 28.07.2013, p. 455-462.

Research output: Contribution to journalArticle

TY - JOUR

T1 - MiR-145 functions as a tumor suppressor by directly targeting histone deacetylase 2 in liver cancer

AU - Noh, Ji Heon

AU - Chang, Young Gyoon

AU - Kim, Min Gyu

AU - Jung, Kwang Hwa

AU - Kim, Jeong Kyu

AU - Bae, Hyun Jin

AU - Eun, Jung Woo

AU - Shen, Qingyu

AU - Kim, Seung Jin

AU - Kwon, So Hee

AU - Park, Won Sang

AU - Lee, Jung Young

AU - Nam, Suk Woo

PY - 2013/7/28

Y1 - 2013/7/28

N2 - Aberrant regulation of histone deacetylase 2 (HDAC2) plays a pivotal role in the development of hepatocellular carcinoma (HCC), but, the underlying mechanism leading to HDAC2 overexpression is not well understood. We performed microRNA (miRNA) profiling analysis in a subset of HCCs, and identified four down-regulated miRNAs that may target HDAC2 in HCC. Ectopic expression of miRNA mimics evidenced that miR-145 suppresses HDAC2 expression in HCC cells. This treatment repressed cancer cell growth and recapitulated HDAC2 knockdown effects on HCC cells. In conclusion, we suggest that loss or suppression of miR-145 may cause aberrant overexpression of HDAC2 and promote HCC tumorigenesis.

AB - Aberrant regulation of histone deacetylase 2 (HDAC2) plays a pivotal role in the development of hepatocellular carcinoma (HCC), but, the underlying mechanism leading to HDAC2 overexpression is not well understood. We performed microRNA (miRNA) profiling analysis in a subset of HCCs, and identified four down-regulated miRNAs that may target HDAC2 in HCC. Ectopic expression of miRNA mimics evidenced that miR-145 suppresses HDAC2 expression in HCC cells. This treatment repressed cancer cell growth and recapitulated HDAC2 knockdown effects on HCC cells. In conclusion, we suggest that loss or suppression of miR-145 may cause aberrant overexpression of HDAC2 and promote HCC tumorigenesis.

UR - http://www.scopus.com/inward/record.url?scp=84878249332&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878249332&partnerID=8YFLogxK

U2 - 10.1016/j.canlet.2013.03.003

DO - 10.1016/j.canlet.2013.03.003

M3 - Article

C2 - 23499894

AN - SCOPUS:84878249332

VL - 335

SP - 455

EP - 462

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

IS - 2

ER -